These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23409762)

  • 21. Structural insights into G-protein-coupled receptor allostery.
    Thal DM; Glukhova A; Sexton PM; Christopoulos A
    Nature; 2018 Jul; 559(7712):45-53. PubMed ID: 29973731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional selectivity in GPCR modulator screening.
    Kenakin T
    Comb Chem High Throughput Screen; 2008 Jun; 11(5):337-43. PubMed ID: 18537555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular Receptor Modulation: Novel Approach to Target GPCRs.
    Ortiz Zacarías NV; Lenselink EB; IJzerman AP; Handel TM; Heitman LH
    Trends Pharmacol Sci; 2018 Jun; 39(6):547-559. PubMed ID: 29653834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When simple agonism is not enough: emerging modalities of GPCR ligands.
    Smith NJ; Bennett KA; Milligan G
    Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors.
    Bartuzi D; Kaczor AA; Matosiuk D
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28714871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.
    Kenakin T; Miller LJ
    Pharmacol Rev; 2010 Jun; 62(2):265-304. PubMed ID: 20392808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiling of orthosteric and allosteric group-III metabotropic glutamate receptor ligands on various G protein-coupled receptors with Tag-lite
    Belhocine A; Veglianese P; Hounsou C; Dupuis E; Acher F; Durroux T; Goudet C; Pin JP
    Neuropharmacology; 2018 Sep; 140():233-245. PubMed ID: 30099051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation.
    Changeux JP; Christopoulos A
    Cell; 2016 Aug; 166(5):1084-1102. PubMed ID: 27565340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAM-Antagonists: A Better Way to Block Pathological Receptor Signaling?
    Kenakin T; Strachan RT
    Trends Pharmacol Sci; 2018 Aug; 39(8):748-765. PubMed ID: 29885909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G-protein-coupled receptor allosterism: the promise and the problem(s).
    Christopoulos A; May LT; Avlani VA; Sexton PM
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):873-7. PubMed ID: 15494038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65.
    Huang XP; Karpiak J; Kroeze WK; Zhu H; Chen X; Moy SS; Saddoris KA; Nikolova VD; Farrell MS; Wang S; Mangano TJ; Deshpande DA; Jiang A; Penn RB; Jin J; Koller BH; Kenakin T; Shoichet BK; Roth BL
    Nature; 2015 Nov; 527(7579):477-83. PubMed ID: 26550826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
    Fronik P; Gaiser BI; Sejer Pedersen D
    J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosteric Modulators of the Class A G Protein Coupled Receptors.
    Tschammer N
    Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seven transmembrane receptors as nature's prototype allosteric protein: de-emphasizing the geography of binding.
    Kenakin TP
    Mol Pharmacol; 2008 Sep; 74(3):541-3. PubMed ID: 18583453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [G-protein-coupled receptors targeting: the allosteric approach].
    Sebag JA; Pantel J
    Med Sci (Paris); 2012 Oct; 28(10):845-51. PubMed ID: 23067415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A conformation-equilibrium model captures ligand-ligand interactions and ligand-biased signalling by G-protein coupled receptors.
    Roth S; Bruggeman FJ
    FEBS J; 2014 Oct; 281(20):4659-71. PubMed ID: 25145284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Molecular Basis of G Protein-Coupled Receptor Activation.
    Weis WI; Kobilka BK
    Annu Rev Biochem; 2018 Jun; 87():897-919. PubMed ID: 29925258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The operational model of allosteric modulation of pharmacological agonism.
    Jakubík J; Randáková A; Chetverikov N; El-Fakahany EE; Doležal V
    Sci Rep; 2020 Sep; 10(1):14421. PubMed ID: 32879329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of conformational ensembles of seven transmembrane receptors in functional selectivity.
    Vaidehi N; Kenakin T
    Curr Opin Pharmacol; 2010 Dec; 10(6):775-81. PubMed ID: 20933468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.